<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Bach Balling | Activity</title>
	<link>https://www.catswannabecats.com/members/flagmaple0/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/flagmaple0/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Bach Balling.</description>
	<lastBuildDate>Mon, 22 Jun 2026 11:40:09 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">fc9ada20c55dbfbc6a5bc836e12b5f06</guid>
				<title>Bach Balling posted an update: The overall cancer detection rate was 4.1/1000 screened [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/25760/</link>
				<pubDate>Mon, 09 Jun 2025 11:43:07 -0400</pubDate>

									<content:encoded><![CDATA[<p>The overall cancer detection rate was 4.1/1000 screened women. Positive predictive value of screening was 4.7% with a sensitivity rate of 53% and specificity of 92%. This study showed a low mammography adherence among previously screened women. The study revealed low sensitivity, high specificity, and an acceptable cancer detection rate. Future&hellip;<span class="activity-read-more" id="activity-read-more-25760"><a href="https://www.catswannabecats.com/activity/p/25760/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">32512fcb12af08dbd7d7a16a9751b302</guid>
				<title>Bach Balling posted an update: and no risk difference of neonatal outcomes in younger [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23759/</link>
				<pubDate>Sun, 08 Jun 2025 10:29:22 -0400</pubDate>

									<content:encoded><![CDATA[<p>and no risk difference of neonatal outcomes in younger pregnancy adolescents. It potentially suggests that GPC model to care pregnant adolescents is more important than the age of pregnant adolescent, however further research is needed.Objectives Superior Vena Cava (SVC) flow in neonates measured by the standard approach has been validated by&hellip;<span class="activity-read-more" id="activity-read-more-23759"><a href="https://www.catswannabecats.com/activity/p/23759/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">18bb32067591765b46cb304495217c45</guid>
				<title>Bach Balling posted an update: We have created a bleeding leg simulator using inexpensive [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20080/</link>
				<pubDate>Thu, 05 Jun 2025 11:15:47 -0400</pubDate>

									<content:encoded><![CDATA[<p>We have created a bleeding leg simulator using inexpensive and readily available materials to teach civilians in resource-poor settings how to control exsanguinating hemorrhage until the patient can be brought to the hospital, as commercially available mannequins are often too expensive in these settings. Items used include a leg of lamb, IV&hellip;<span class="activity-read-more" id="activity-read-more-20080"><a href="https://www.catswannabecats.com/activity/p/20080/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9b9317976c073fe715506eed09a42bdc</guid>
				<title>Bach Balling posted an update: The 3-year LFS were 58 %, 62 % and 25 % for patients within [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18459/</link>
				<pubDate>Tue, 03 Jun 2025 13:46:40 -0400</pubDate>

									<content:encoded><![CDATA[<p>The 3-year LFS were 58 %, 62 % and 25 % for patients within ELN favorable-, intermediate-, and adverse-risk groups respectively. <a href="https://www.selleckchem.com/products/ro-20-1724.html" rel="nofollow ugc">Ro 20-1724 datasheet</a> Twenty-seven (36 %) out of 75 patients with intermediate- and adverse-risk disease underwent allogeneic hematopoietic cell transplantation (allo-HCT) in first CR with 92 % of them receiving&hellip;<span class="activity-read-more" id="activity-read-more-18459"><a href="https://www.catswannabecats.com/activity/p/18459/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d289199949a100a671db2a5cb7554366</guid>
				<title>Bach Balling became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/11274/</link>
				<pubDate>Sun, 01 Jun 2025 05:35:19 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>